| Literature DB >> 26035490 |
Sophal Cheat1,2,3, Juliana R Gerez4,5,6, Juliette Cognié7, Imourana Alassane-Kpembi8,9,10, Ana Paula F L Bracarense6, Isabelle Raymond-Letron11,12, Isabelle P Oswald13,14, Martine Kolf-Clauw8,9.
Abstract
The mycotoxins deoxynivalenol (DON) and nivalenol (NIV), worldwide cereal contaminants, raise concerns for animal and human gut health, following contaminated food or feed ingestion. The impact of DON and NIV on intestinal mucosa was investigated after acute exposure, in vitro and in vivo. The histological changes induced by DON and NIV were analyzed after four-hour exposure on pig jejunum explants and loops, two alternative models. On explants, dose-dependent increases in the histological changes were induced by DON and NIV, with a two-fold increase in lesion severity at 10 µM NIV. On loops, NIV had a greater impact on the mucosa than DON. The overall proliferative cells showed 30% and 13% decrease after NIV and DON exposure, respectively, and NIV increased the proliferative index of crypt enterocytes. NIV also increased apoptosis at the top of villi and reduced by almost half the proliferative/apoptotic cell ratio. Lamina propria cells (mainly immune cells) were more sensitive than enterocytes (epithelial cells) to apoptosis induced by NIV. Our results demonstrate a greater impact of NIV than DON on the intestinal mucosa, both in vitro and in vivo, and highlight the need of a specific hazard characterization for NIV risk assessment.Entities:
Keywords: deoxynivalenol; enterocytes; histomorphology; jejunum explant; loops; mycotoxins; nivalenol
Mesh:
Substances:
Year: 2015 PMID: 26035490 PMCID: PMC4488683 DOI: 10.3390/toxins7061945
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Histological scores of jejunal explants. (I) Explants exposed to different treatments: T0 (Time 0H, before culture ), T4/WME (4 h in William’s medium E), T4/WME + 0.1%DMSO (dimethylsulfoxyde), DON (deoxynivalenol) or NIV (nivalenol): 1, 3 and 10 µM. Values are mean ± SEM. (II) Effect of DON and NIV on the histological score after 4 hours of exposure. Values are mean ± SEM. a, b, c scripts are different at p ≤ 0.05 by Tukey’s test (II) (a) Jejunal explant uncultured (T0; n = 12). Slight dilatation of the lymphatic vessels (arrow), HE (hematoxylin-eosin), ×200; (b) explants exposed to WME with 0.1% DMSO (DMSO n = 42). Edema of the lamina propria and mild villus atrophy (arrow), HE ×200; (c) 3 µM DON-exposed explant. Moderate fusion and cubic epithelial cells (arrow) (HE, ×200); (d) 10 µM NIV-exposed explant. Fusion and atrophy of villi with severely flattened epitelium (arrow) and apical denudation of villi (dotted arrow) (HE, ×200).
Figure 2Jejunum morphology in a non-loop segment (a) and in a control loop (b) showing vascular changes in the submucosa (large arrow) and edema of the villi central lymphatic vessels (thin arrows); (c) Ki-67 immunostaining in a control loop, showing the methodology for morphometric and proliferation assessments.
Figure 3Morphometric analysis of the jejunum loops: crypt-depth to villus-height ratio after DON and NIV exposure at 10 µM for 4 h. Mean values ± SEM expressed as % of the control group; a, b scripts are different at p ≤ 0.05; Tukey’s test; n = 3 to 6 loops, 30 well-oriented villi and crypts per loop.
Figure 4Proliferation and apoptosis in the jejunum loops after DON and NIV exposure at 10 µM for 4 h. Mean values ± SEM expressed as % of the control group (Ctrl) (A) total cell proliferation at villus tip (upper one-third), p < 0.001; (B) proliferative index of crypt enterocytes, p = 0.001; (C) lamina propria apoptosis at villus tip (upper one-third), p < 0.001; and (D) total proliferating cells to total apoptotic cell ratio, at villus tip p < 0.001. a, b, c scripts are different at p ≤ 0.05; Tukey’s test; n = 3 to 6 loops, 20 villi/loop.
Explants histological scoring: endpoints used and severity factor.
| Score component | Criteria (severity factor) | End-point | Score |
|---|---|---|---|
| Lesional part of the Score | Enterocytes morphology (2) | Columnar epithelium | 3 |
| <50% cuboid epithelium | 2 | ||
| >50% cuboid epithelium | 1 | ||
| Flattened epithelium | 0 | ||
| Apical denudation of villi (2) | 0%–10% | 3 | |
| 11%–40% | 2 | ||
| 41%–70% | 1 | ||
| 71%–100% | 0 | ||
| Lesions of | No lesions, slight flattening of villi | 2 | |
| Localized edema and apoptosis | 1 | ||
| Multifocal edema and apoptosis | 0 | ||
| Architectural part of the Score | Villi fusion (1) | 0%–11% | 3 |
| 12%–40% | 2 | ||
| 41%–70% | 1 | ||
| 71%–100% | 0 | ||
| Number of villi (1) | ≥25 | 3 | |
| 16–24 | 2 | ||
| 5–15 | 1 | ||
| ≤4 | 0 |
Summary of the cell counts and indexes used for assessing proliferation and apoptosis in loops.
| Endpoint | Counted area ( | Cells counts | Indexes |
|---|---|---|---|
| Villus tip | Total cells: | ||
| Crypt bases | Crypt enterocytes | Proliferative index of crypt enterocytes: number of positive enterocytes/total number of enterocytes (×100) | |
| Villus tip | Enterocytes | Enterocyte apoptotic index: number of positive enterocytes/total number of enterocytes (×100) | |
| Villus tip | Total cells: | Total-cell proliferation to total cell apoptosis ratio | |